Effect of Thymalin on the Tumor and Thymus under Conditions of Activation Therapy In Vivo
- 作者: Zhukova G.1, Schikhlyarova A.1, Barteneva T.1, Shevchenko A.1, Zakharyuta F.1
-
隶属关系:
- Rostov Research Institute of Oncology, Ministry of Health of the Russian Federation
- 期: 卷 165, 编号 1 (2018)
- 页面: 80-83
- 栏目: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/239995
- DOI: https://doi.org/10.1007/s10517-018-4104-z
- ID: 239995
如何引用文章
详细
Pronounced antitumor effect of Thymalin in doses lower than the therapeutic doses was shown in experiments on albino outbred male rats with transplanted sarcoma 45. Tumor growth arrest and its regression were observed in more than half of animals and in other cases, the growth was suppressed by 78%. Microstructural changes in the thymus were analyzed. Significant increase in lymphoproliferative activity and the content of tissue basophils and plasmocytes in the thymus lobules was observed. Tumor regression was accompanied by the development of stable antistress adaptation reactions of calm and elevated activation. High efficiency of Thymalin can be attributed to the use of lower doses of the substance and their modulation during the treatment course in accordance with the regimes of activation therapy.
作者简介
G. Zhukova
Rostov Research Institute of Oncology, Ministry of Health of the Russian Federation
编辑信件的主要联系方式.
Email: galya_57@mail.ru
俄罗斯联邦, Rostov-on-Don
A. Schikhlyarova
Rostov Research Institute of Oncology, Ministry of Health of the Russian Federation
Email: galya_57@mail.ru
俄罗斯联邦, Rostov-on-Don
T. Barteneva
Rostov Research Institute of Oncology, Ministry of Health of the Russian Federation
Email: galya_57@mail.ru
俄罗斯联邦, Rostov-on-Don
A. Shevchenko
Rostov Research Institute of Oncology, Ministry of Health of the Russian Federation
Email: galya_57@mail.ru
俄罗斯联邦, Rostov-on-Don
F. Zakharyuta
Rostov Research Institute of Oncology, Ministry of Health of the Russian Federation
Email: galya_57@mail.ru
俄罗斯联邦, Rostov-on-Don